Ovarian metastasis on transposed ovary in patients treated for squamous cell carcinoma of the uterine cervix: report of two cases and surgical implications.
BACKGROUND
To discuss risk factors for ovarian metastasis in a transposed ovary in patients treated for cervical cancer.


METHODS
Cases were two patients with ovarian metastasis in a transposed ovary in a series of 107 patients. These two patients were treated for a Stage IB squamous cell cervical cancer and presented with a tumor devoid of extrauterine spread (absence of nodal involvement or distant metastases) but with involvement of the uterine corpus. Furthermore, lymphovascular space involvement (LVSI) in the cervix or paracervix was present in both patients.


CONCLUSIONS
Ovarian transposition should be performed in patients < or =40 years of age with a small invasive cervical carcinoma (< 3 cm) treated by primary surgery. This procedure should not be performed in patients with bulky tumor and/or in patients with LVSI.
Morice
P
P
Department of Gynecologic Surgery, Radiotherapy, and Oncology, Institut Gustave Roussy, Villejuif, 94805, France.
Haie-Meder
C
C
Pautier
P
P
Lhomme
C
C
Castaigne
D
D
D000328:Adult; D002294:Carcinoma, Squamous Cell / Q000556:secondary* / Q000601:surgery*; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000556:secondary*; D010053:Ovary / Q000601:surgery*; D002583:Uterine Cervical Neoplasms / Q000473:pathology / Q000601:surgery*